Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiovascular Consequences of Hypogonadism in Men
NCT02758431Completed
- Sponsor
- University of Colorado Denver
- Start
- Jul 2016
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of Testosterone TEPI patch in Hypogonadism (3 arms), sponsored by University of Colorado Denver. Primary endpoints: Endothelial function at 28 days, Carotid artery compliance at 28 days and 2 more. Started Jul 2016; status: completed.
02
Drugs
Testosterone TEPI patch
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT02758431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02758431.